Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.

[1]  B. Costall,et al.  Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors? , 1980, European journal of pharmacology.

[2]  R. Yalow,et al.  Brain cholecystokinin in fasted and fed mice. , 1980, Life sciences.

[3]  C. Baile,et al.  CCK-octapeptide injected in CSF decreases meal size and daily food intake in sheep , 1980, Peptides.

[4]  R. D. Myers,et al.  Cholecystokinin acts on the hypothalamic “noradrenergic system” involved in feeding , 1980, Peptides.

[5]  R. Wilcox,et al.  Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity , 1980, Pharmacology Biochemistry and Behavior.

[6]  G. Zetler.  Antagonism of cholecystokinin-like peptides by opioid peptides, morphine or tetrodotoxin. , 1979, European journal of pharmacology.

[7]  J. Rehfeld,et al.  Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system , 1979, Brain Research.

[8]  C. Baile,et al.  Cholecystokinin, amphetamine and diazepam and feeding in lean and obese Zucker rats , 1979, Pharmacology Biochemistry and Behavior.

[9]  R. Yalow,et al.  Cholecystokinin in the brains of obese and nonobese mice. , 1979, Science.

[10]  M. Runswick,et al.  Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain , 1978, Nature.

[11]  H. Fibiger,et al.  Direct evidence for presynaptic and postsynaptic dopamine receptors in brain , 1978, Nature.

[12]  J. Rehfeld,et al.  Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. , 1978, The Journal of biological chemistry.

[13]  D. Jacobowitz,et al.  Method for the rapid determination of norepinephrine, dopamine, and serotonin in the same brain region , 1978, Pharmacology Biochemistry and Behavior.

[14]  M. Hershkowitz,et al.  The effects of dibutyryl cyclic AMP, theophylline and papaverine on the release of 3H-catecholamines from rat brain striatal and cortical synaptosomes. , 1977, European journal of pharmacology.

[15]  W. A. Hunt,et al.  Reduction of striatal dopamine release during an ethanol withdrawal syndrome , 1977, Journal of neurochemistry.

[16]  R. Yalow,et al.  Cholecystokinin and its COOH-terminal octapeptide in the pig brain. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Yalow,et al.  Immunohistochemical localization in rabbit brain of a peptide resembling the COOH-terminal octapeptide of cholecystokinin. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Chiara,et al.  Postsynaptic receptors are not essential for dopaminergic feedback regulation , 1977, Nature.

[19]  G. Dockray,et al.  Immunochemical evidence of cholecystokinin-like peptides in brain , 1976, Nature.

[20]  G. Chiara,et al.  Evidence for dopamine receptors mediating sedation in the mouse brain , 1976, Nature.

[21]  J. Vanderhaeghen,et al.  New peptide in the vertebrate CNS reacting with antigastrin antibodies , 1975, Nature.

[22]  G. P. Smith,et al.  Cholecystokinin elicits the complete behavioral sequence of satiety in rats. , 1975, Journal of comparative and physiological psychology.

[23]  B. Penke,et al.  Effects of intracerebroventricular administration of cholecystokinin-octapeptide-sulfate-ester on dopamine, norepinephrine and serotonin contents of different brain structures in rats , 1980 .

[24]  P. McHugh,et al.  Cholecystokinin-decreased food intake in rhesus monkeys. , 1976, The American journal of physiology.